Patents Assigned to ENHANCE SKIN PRODUCTS, INC.
  • Publication number: 20170181943
    Abstract: The present invention relates to methods for enhancing, extending and accelerating the cosmetic benefits certain non-surgical dermal interventions, examples of which include treatment with aesthetic injectables such as botulinum toxin and dermal fillers, as well as intense pulsed light (IPL) treatments, particularly cosmetic treatments characterized by the injection of botulinum toxin compositions, such as Botox® and Dysport®, and/or dermal fillers, such as Restylane® and Juviderm®. More particularly, the present invention relates to the unexpected discovery that the combination of micron-sized particulate bioactive glass and medical grade hyaluronic acid yields a cosmetic composition that is capable of improving and prolonging the anti-wrinkle effects of such cosmetic therapies as well as to afford enhanced and improved healing and anti-microbial benefits at the site(s) of injection.
    Type: Application
    Filed: March 27, 2015
    Publication date: June 29, 2017
    Applicants: ENHANCE SKIN PRODUCTS, INC.
    Inventors: Gary D. HACK, Samuel S. ASCULAI
  • Patent number: 8758819
    Abstract: A cosmetic composition comprising at least one compound selected from bioactive/biocompatible microparticulates such as bioactive glass or bioactive ceramics, and an intradermal delivery vehicle selected from the group consisting of hyaluronans, hyaluronic acid and/or salts thereof and/or homologues, analogues, derivatives, complexes, esters, fragments and subunits of hyaluronic acid in an amount sufficient to facilitate deposition and penetration of said bioactive microparticulates through tissue at a site to be treated.
    Type: Grant
    Filed: September 7, 2007
    Date of Patent: June 24, 2014
    Assignee: Enhance Skin Products, Inc.
    Inventor: Samuel Asculai
  • Publication number: 20100003340
    Abstract: A cosmetic composition comprising at least one compound selected from bioactive/biocompatible microparticulates such as bioactive glass or bioactive ceramics, and an intradermal delivery vehicle selected from the group consisting of hyaluronans, hyaluronic acid and/or salts thereof and/or homologues, analogues, derivatives, complexes, esters, fragments and subunits of hyaluronic acid in an amount sufficient to facilitate deposition and penetration of said bioactive microparticulates through tissue at a site to be treated
    Type: Application
    Filed: September 7, 2007
    Publication date: January 7, 2010
    Applicant: ENHANCE SKIN PRODUCTS, INC.
    Inventor: Samuel Asculai